Charitable giving by affluent Americans in 2020 averaged $43,195, a 48 percent increase over $29,269 in 2017, a report from Bank of America and Indiana University Lilly Family School of Philanthropy finds. To read the full report, go to scholarworks.iupui.edu/bitstream/handle/1805/26654/bank-america-sept21.pdf.
From Philanthropy News Digest website, accessed Sept. 30, 2021.

Kristi Howard-Shultz, writing for the Lilly Family School of Philanthropy blog, provided tips on hiring grant writers in her recent post. According to Howard-Shultz, a nonprofit should ask professional grant writers if they have direct experience in the nonprofit’s sector and require writers to clearly outline their writing and communication process. For more tips, go to blog.philanthropy.iupui.edu/2021/09/28/how-to-hire-a-successful-grant-writer/.
From Lilly Family School of Philanthropy website, accessed Sept. 29, 2021.

SOURCE: Centers for Disease Control and Prevention (CDC)
APPLICATION DEADLINE: Nov. 19, 2021.
$ AVAILABLE: $55 million for 30 awards.
ELIGIBILITY: The applicant must have a history of having provided HIV prevention services in the applicant's jurisdiction, discussed provision of services with their state or local health department in which they report HIV diagnoses, and received written consent from the state or local health department. 
Applicants are eligible to apply for funding under one category (Category A or B). This Notice of Funding Opportunity (NOFO) is seeking applications from organizations that were founded for the purpose of serving the selected priority population(s) and are rooted or embedded within the communities they serve. Applicants may provide HIV prevention services in a maximum of three service areas within the applicant's jurisdiction. Applicants can provide HIV prevention services in areas that cross over into bordering state health department jurisdictions. 
PURPOSE: The CDC announces the availability of Fiscal Year (FY) 2022 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement high-impact HIV prevention programs in the following two categories:
• Category A: HIV prevention services for Young Men of Color Who Have Sex with Men (YMSM of color) and their partners regardless of age, gender, and race/ethnicity.
• Category B: HIV prevention services for Young Transgender Persons of Color (YTG persons of color) and their partners regardless of age, gender, and race/ethnicity.
CFDA: 93.939
CONTACT: Please see URL for multiple contacts. For more information, go to www.grants.gov/web/grants/view-opportunity.html?oppId=331873.
From Grants.gov website, accessed Sept. 28, 2021. 
Subject(s): HIV/AIDS services.
 

SOURCE: National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS)
APPLICATION DEADLINE: Letter of Intent: Nov. 7, 2021. Due Date: Dec. 7, 2021. All applications are due by 5 p.m. local time of applicant organization.
$ AVAILABLE: NIMH intends to commit a total of $2 million in Fiscal Year (FY) 2022 to fund three to five awards in response to this Funding Opportunity Announcement (FOA) and the companion FOA. NINDS intends to commit a total of $1.5 million in FY 2022 to fund three to five awards in response to this FOA and the companion FOA. Future year amounts will depend on annual appropriations.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
• Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The purpose of this FOA is to support studies to better comprehend the mechanisms contributing to the Central Nervous System (CNS) co-morbidities in people living with HIV on Anti-Retroviral therapy by deciphering the Immune-Central Nervous System interactions. Applications testing a fully conceptualized and hypothesis-based premise founded on adequate preliminary data are appropriate for this FOA. Applicants pursuing exploratory and high-risk research projects should be submitted to the companion R21 announcement, RFA-MH-21-251.
CFDA: 93.242, 93.853
CONTACT: Please see URL for multiple contacts. For more information, go to grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-250.html.
From Grants.gov website, accessed Sept. 30, 2021. 
Subject(s): HIV/AIDS research.

SOURCE: National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS)
APPLICATION DEADLINE: Letter of Intent: Nov. 7, 2021. Due Date: Dec. 7, 2021. All applications are due by 5 p.m. local time of applicant organization.
$ AVAILABLE: NIMH intends to commit a total of $2 million in Fiscal Year (FY) 2022 to fund three to five awards in response to this Funding Opportunity Announcement (FOA) and the companion FOA. NINDS intends to commit a total of $1.5 million in FY 2022 to fund three to five awards in response to this FOA and the companion FOA. Future year amounts will depend on annual appropriations.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
• Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The purpose of this Funding Opportunity Announcement (FOA) is to support studies to comprehend the mechanisms contributing to the Central Nervous System (CNS) co-morbidities in people living with HIV (PLHIV) on Anti-Retroviral therapy (ART) by deciphering the Immune-Central Nervous System interactions utilizing novel in-vitro and in-vivo model systems. Exploratory and high-risk research projects are appropriate for this FOA.
CFDA: 93.242, 93.853
CONTACT: Please see URL for multiple contacts. For more information, go to grants.nih.gov/grants/guide/rfa-files/RFA-MH-21-251.html.
From Grants.gov website, accessed Sept. 29, 2021. 
Subject(s): HIV/AIDS research.
 

SOURCE: National Institutes of Health (NIH)
APPLICATION DEADLINE: Letter of Intent: Dec. 11, 2021; April 1, 2022. Due Date: Jan. 11, 2022; May 3, 2022. Expires Sept. 9, 2024. All applications are due by 5 p.m. local time of applicant organization.
Please see URL for additional due dates.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) will support pilot, feasibility, or exploratory research in priority areas in substance use epidemiology, prevention, and health services.
CFDA: 93.279
CONTACT: Please see URL for multiple contacts. For more information, go to grants.nih.gov/grants/guide/pa-files/PAR-22-027.html.
From Grants.gov website, accessed Sept. 29, 2021. 
Subject(s): substance abuse, medical research.
 

SOURCE: National Institutes of Health (NIH), National Cancer Institute (NCI)
APPLICATION DEADLINE: Letter of Intent: Oct. 12, 2021; Jan. 5, 2022. Due Date: Nov. 12, 2021; Feb. 5, 2022. Expires Sept. 8, 2024. All applications are due by 5 p.m. local time of applicant organization. Please see URL for additional due dates.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes.
CFDA: 93.393, 93.396, 93.399
CONTACT: Please see URL for multiple contacts. For more information, go to grants.nih.gov/grants/guide/pa-files/PAR-21-331.html.
From Grants.gov website, accessed Sept. 30, 2021. 
Subject(s): cancer research.
 

SOURCE: National Institutes of Health (NIH), National Cancer Institute (NCI)
APPLICATION DEADLINE: Letter of Intent: Oct. 18, 2021; Jan. 14, 2022. Due Date: Nov. 18, 2021; Feb. 16, 2022. Expires Sept. 8, 2024. All applications are due by 5 p.m. local time of applicant organization. Please see URL for additional due dates.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: 
• Public/state/private controlled institutions of higher education.
• Hispanic-serving institutions.
• Historically Black Colleges and Universities (HBCUs).
• Tribally Controlled Colleges and Universities (TCCUs).
• Alaska native and native Hawaiian serving institutions.
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
• Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
• Small businesses.
• For-profit organizations (other than small businesses).
• State governments.
• County governments.
• City or township governments.
• Special district governments.
• Indian/Native American tribal governments (federally recognized and other than federally recognized).
• Eligible agencies of the federal government.
• U.S. territories or possessions.
• Independent school districts.
• Public housing authorities/Indian housing authorities.
• Native American tribal organizations (other than federally recognized tribal governments).
• Faith-based or community-based organizations.
• Regional organizations.
PURPOSE: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. The goal of this FOA is to support proof of concept studies for feasibility and exploratory development. Investigators who have generated unpublished preliminary data should submit an application to the companion FOA (PAR-21-331).
CFDA: 93.393, 93.396, 93.399
CONTACT: Please see URL for multiple contacts. For more information, go to grants.nih.gov/grants/guide/pa-files/PAR-21-332.html.
From Grants.gov website, accessed Sept. 30, 2021. 
Subject(s): cancer research.
 

SOURCE: Texas Veterans Commission (TVC)
APPLICATION DEADLINE: Nov. 3, 2021 by 5 p.m. CT.
$ AVAILABLE: Fund for Veterans’ Assistance (FVA) grants are awarded on a cost reimbursement basis. Eligible Applicants can request the specific funding amounts for their grant-funded projects from $5,000 to $500,000. 
ELIGIBILITY: 
• Organizations whose grants were renewed in May 2021.
• Units of local government.
• IRS Code § 501(c)(19) posts or organizations of past or present members of the Armed Forces.
• IRS Code § 501(c)(3) private nonprofit organizations authorized to do business in Texas.
• Texas chapters of IRS Code § 501(c)(4) veterans service organizations.
• Nonprofit organizations authorized to do business in Texas with experience providing services to veterans.
PURPOSE: FVA grants help Texas units of local government and qualified nonprofit organizations to address the needs of veterans and their families in their local communities. Funding opportunities are issued yearly in the General Assistance, Housing for Texas Heroes, Veterans Mental Health, and Veterans Treatment Court grant programs through a competitive selection process.
CFDA: None.
CONTACT: Email: grants@tvc.texas.gov. For more information, go to www.tvc.texas.gov/grants/apply/#2022-23.
From Texas Veterans Commission website, accessed Sept. 30, 2021. 
Subject(s): veteran’s services, housing/homeless, mental health, criminal justice/correctional.

SOURCE: Cystic Fibrosis Foundation (CFF) 
APPLICATION DEADLINE: Rolling.
$ AVAILABLE: Funds will be awarded only if they are matched by the recipient. This is a two-part program. Funding is determined by which phase the project will pursue. 
• Component (Phase) I – Discovery and/or Preclinical Development: $600,000 over no more than a three-year period.
• Component (Phase) II – Clinical: $3 million to $5 million over no more than a three-year period.
ELIGIBILITY: Both U.S.-based and non-U.S. based companies engaged in research and development are invited to apply. Please see URL for additional eligibility requirements.
PURPOSE: To stimulate development of new pharmaceutical products for Cystic Fibrosis (CF) patients, CFF developed the Therapeutics Development Award Program. The purpose of this program is to provide funds to companies that will develop commercial products to benefit individuals with CF. 
CONTACT: Please see URL for contact information. For more information, go to www.cff.org/Research/Researcher-Resources/Awards-and-Grants/Research-Awards/TDA-Policies-and-Guidelines.pdf.
From Philanthropy News Digest website, accessed Sept. 28, 2021.
Subject(s): medical research, respiratory system diseases.
 

SOURCE: Pfizer Global Medical Grants (GMG)
APPLICATION DEADLINE: Letter of Intent: Nov. 5, 2021. Full proposal due date: Feb. 2022, exact date not specified.
$ AVAILABLE: Individual projects requesting up to $250,000 will be considered. Pfizer anticipates a total fund of $1 million.
ELIGIBILITY: 
• Only organizations are eligible to receive grants, not individuals or medical practice groups.
• The applicant Principal Investigator (PI) must have a medical or postdoctoral degree (M.D., Ph.D., or equivalent), an advanced nursing degree (B.S.N.with a M.S./Ph.D.), or a degree in Pharmacy, Physiotherapy, or Social Work.
• Applicant must be affiliated with a host institution.
• Both early career and experienced investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria.
PURPOSE: In-scope research includes:
• Pathophysiology and biology of overweight and obesity.
• Understanding obesity as a disease.
• Utilizing retrospective databases, generating evidence of optimal management of obesity and co-existing comorbid conditions.
CONTACT: Grant Officer, Jessica Romano. Email: jessica.romano@pfizer.com. For more information, go to cdn.pfizer.com/pfizercom/2021-09/2021-2022%20Global%20Obesity%20ASPIRE.pdf?K5KIDbSHZmOf8xK_JkpHapTbEfbFP2DU.
From Pfizer Global Medical Grants website, accessed Sept. 22, 2021.
Subject(s): medical research, obesity.  

SOURCE: RADx-UP Coordination and Data Collection Center (CDCC)
APPLICATION DEADLINE: Letter of Interest: Nov. 19, 2021; April 22, 2022. Due Date: Dec. 10, 2021; May 13, 2022. Expires Jan. 13, 2023. Please see URL for additional due dates.
$ AVAILABLE: The mini-grant budget covers expenditures of up to $50,000 in direct costs for a 12-month period.
ELIGIBILITY: The following organizations are eligible to apply: community serving organizations, faith-based organizations, community-based clinics, and tribal nations and organizations. The CDCC is interested in receiving proposals to work with underserved and vulnerable communities not currently engaged with existing RADx-UP awardees; the awardees of the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities program; and from organizations with a track record of outreach and service to underserved and vulnerable populations. Though not required, the CDCC also encourages partnerships with existing RADx-UP and CEAL awardees who may be able to collaborate with mini-grant sub-awardees on their outreach and communication, testing, and data collection and dissemination strategies. Eligible organizations may also include in their applications, collaborations with academic institutions, clinical practices, and others.
PURPOSE: The CDCC’s Community Collaboration Mini-Grant Program seeks to support the inclusion of additional community partners and stakeholder groups who are not currently part of the RADx-UP program through CDCC subawards. This program will provide CDCC subawards (“mini-grants”) to increase the capacity for COVID-19 testing expertise within the community. The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in underserved, COVID-19 medically, geographically, and socially vulnerable populations. This program seeks to increase the capacity for COVID-19 testing expertise within the community. Increasing training, education, communication, information dissemination, and capacity building related to COVID-19 testing, isolation, and contact tracing in communities will increase the ability to decrease COVID-19 transmission and save lives.
CONTACT: Please see URL for contact information. For more information, go to radx-up.org/apply-for-grant/?open=grant.
From RADx-UP Coordination and Data Collection Center (CDCC) website, accessed Sept. 30, 2021.
Subject(s): coronavirus disease 2019 (COVID-19).
 

SOURCE: RADx-UP Coordination and Data Collection Center (CDCC)
APPLICATION DEADLINE: Letter of Interest: Nov. 19, 2021; April 22, 2022. Due Date: Dec. 10, 2021; May 13, 2022. Expires Jan. 13, 2023. Please see URL for additional due dates.
$ AVAILABLE: The amount of the subaward for each Rapid Pilot is up to $200,000 in direct costs, to be expended over one year.
ELIGIBILITY: Eligible organizations are institutions of higher education, industry, state and local governments, and community-based organizations that have the infrastructure to manage such funding. Historically black colleges and universities (HBCUs), tribally controlled colleges and universities (TCCUs), Hispanic-serving institutions, and other minority-serving institutions are encouraged to apply. The RADx-UP Coordination and Data Collection Center (CDCC) is particularly interested in receiving proposals developed jointly with community-based organizations and encourages partnerships across these different types of organizations to form interdisciplinary teams, including public-private partnerships. Applications with multiple Principal Investigators (co-PIs) must identify one PI as the main contact PI, with primary responsibility for the administrative aspects of the pilot subaward.
PURPOSE: The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in communities of underserved and vulnerable populations. The Rapid Research Pilot program is focused on evaluating the feasibility of implementing emerging COVID-19 testing technologies in underserved communities.
CONTACT: Please see URL for contact information. For more information, go to radx-up.org/apply-for-grant/?open=pilot.
From RADx-UP Coordination and Data Collection Center (CDCC) website, accessed Sept. 30, 2021.
Subject(s): coronavirus disease 2019 (COVID-19).

SOURCE: Marsha Rivkin Center for Ovarian Cancer Research
APPLICATION DEADLINE: Dec. 1, 2021 by 4 p.m. CT.
$ AVAILABLE: The two-year awards will provide a total of $75,000 in funding, with the possibility of an additional $25,000 awarded in year two, upon evaluation of year one progress, contingent on availability of funds. 
ELIGIBILITY: Investigators at the assistant, associate, or full professor level (or equivalent) are encouraged to apply.
PURPOSE: Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered.
CONTACT: Jackie Lang, Ph.D. Phone: 206-584-2357. Email: Jackie.Lang@rivkin.org. For more information, go to www.rivkin.org/research/grants/pilot-study-awards.
From Rivkin Center website, accessed Sept. 30, 2021.
Subject(s) cancer research.

SPONSOR: National Institutes of Health (NIH)
WHEN: Nov. 1-4, 7 a.m.-4:45 p.m. CT.
WHERE: Online.
DESCRIPTION: If you’re new to working with the NIH grants process as an investigator or administrator, then mark your calendar for a unique opportunity to learn, share, and meet virtually with NIH and U.S. Department of Health and Human Services (HHS) experts. The NIH is offering a virtual seminar with live and simu-live sessions, as well as an on-demand video library, three tracks designed around grants policies, processes, case-studies and Q&As; and live chats one-on-one with NIH & HHS experts on the grants process and policies.
COST: Free. For more information and registration, go to grants.nih.gov/2021-nih-virtual-seminar.htm.
CONTACT: Email: NIHRegionalSeminars@nih.gov.
From NIH website, accessed Sept. 29, 2021.

SPONSOR: Grant Professional Association (GPA)
WHEN: Nov. 3-6. Please see URL for session schedule.
WHERE: Online.
DESCRIPTION: The Grant Professional Association's Annual Conference attracts over 1,000 grant professionals for three days of grant professional learning and networking opportunities. From early-career to advanced/master, the professional development sessions are designed to raise your skills to the next level. 
COST: $325-$595. For more information and registration, go to gpaconf2021.pathable.co/.
CONTACT: Barb Boggs. Email: barb@grantprofessionals.org.
From Grant Professionals Association Conference website, accessed Sept. 30, 2021.

The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to six faculty members at The University of Texas at Austin. The funding will support ongoing, innovative cancer research at UT and enable advances in immunotherapy, drug development and cancer prevention efforts. The grants are among 73 new statewide awards totaling more than $142 million that CPRIT recently announced. 
From University of Texas News website, accessed Sept. 30, 2021.

A new partnership between The University of Texas at El Paso (UTEP), Sul Ross State University in Alpine, Texas, and Preventative Care Health Services (PCHS) in Presidio, Texas, will develop a behavioral health specialists’ workforce to improve access to mental health services in five southwest Texas rural counties. With support from a $1.9 million grant awarded by the Health Services Resources Administration (HSRA) to PCHS, also known as Presidio County Health Services, UTEP and Sul Ross will train students to provide culturally competent mental health care to residents of Presidio, Brewster, Culberson, Hudspeth and Jeff Davis counties.
From University of Texas at El Paso Campus Newsfeed website, accessed Sept. 22, 2021.

Your Shot Texas is investing more than $1.4 million to help community-based organizations increase access to COVID-19 vaccines, battle hesitancy, and make sure communities that have been hit hardest by the virus have an equal shot to get vaccinated. This is the second round of grants awarded in 2021 by the statewide philanthropic effort created by Episcopal Health Foundation in Houston, Methodist Healthcare Ministries of South Texas, Inc. in San Antonio, and The Meadows Foundation in Dallas.
From Episcopal Health Foundation website, accessed Sept. 30, 2021.